Utah Medical Products
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
19.9118.6422.5035.5816.7027.2628.5524.6622.1918.4114.1027.26
Price/Sales ratio
5.495.496.947.307.378.557.317.436.996.094.768.55
Price/Book Value ratio
3.513.173.943.873.483.972.993.403.202.381.733.97
Price/Cash Flow ratio
14.7215.9918.7817.8918.4023.5315.3117.2017.2813.7412.4923.53
Price/Free Cash Flow ratio
15.8916.2824.3019.7618.85-89.5315.9917.6617.9814.1512.24-89.53
Price/Earnings Growth ratio
N/A4.698.83-1.230.14-1.34-1.110.661.8720.852.960.14
Dividend Yield
1.66%1.74%1.43%0.97%1.29%1.02%1.33%3.14%0.86%1.39%1.94%1.29%
Profitability Indicator Ratios
Gross Profit Margin
60.52%60.22%60.28%63.73%62.63%62.82%60.57%63.02%61.58%59.80%55.67%62.82%
Operating Profit Margin
39.25%38.97%41.19%45.90%44.51%22.92%15.40%38.48%24.30%33.40%33.14%22.92%
Pretax Profit Margin
38.30%38.71%41.78%46.07%46.33%38.12%32.81%38.85%39.51%39.99%41.30%41.30%
Net Profit Margin
27.56%29.49%30.86%20.53%44.17%31.39%25.60%30.14%31.50%33.12%34.61%34.61%
Effective Tax Rate
28.04%23.81%26.14%55.42%4.64%17.65%21.97%22.41%20.26%17.19%16.17%4.64%
Return on Assets
14.03%14.95%15.83%9.17%18.59%13.41%9.66%12.79%13.29%12.28%11.76%13.41%
Return On Equity
17.62%17.00%17.51%10.88%20.84%14.56%10.50%13.80%14.41%12.96%12.10%14.56%
Return on Capital Employed
22.47%20.83%22.00%21.73%19.78%10.11%6.02%16.86%10.75%12.83%11.56%10.11%
Liquidity Ratios
Current Ratio
3.308.0811.539.3111.5715.9116.42N/AN/AN/A29.5911.57
Quick Ratio
2.767.0510.038.3210.5413.9114.7818.4814.0920.5226.9410.54
Cash ratio
2.155.738.727.559.7112.4013.6016.9313.0419.7125.759.71
Days of Sales Outstanding
41.5841.4729.8231.9334.38N/A35.5138.1838.6624.2530.80N/A
Days of Inventory outstanding
109.1395.88106.21127.44125.90144.69136.56132.74160.17173.26170.15125.90
Operating Cycle
150.71137.36136.04159.37160.28144.69172.07170.92198.83197.51200.95160.28
Days of Payables Outstanding
20.8014.8321.1822.6922.6722.9817.2915.3122.1313.9018.6622.98
Cash Conversion Cycle
129.90122.53114.85136.67137.61121.71154.78155.61176.70183.61182.28137.61
Debt Ratios
Debt Ratio
0.06N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Equity Ratio
0.07N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Long-term Debt to Capitalization
0.01N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.07N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
56.06240.78N/AN/AN/AN/AN/AN/AN/AN/A8.28N/A
Cash Flow to Debt Ratio
3.16N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.251.131.101.181.121.081.081.071.081.051.041.08
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.370.340.360.400.400.360.470.430.400.440.390.36
Free Cash Flow / Operating Cash Flow Ratio
0.920.980.770.900.97-0.260.950.970.960.970.990.97
Cash Flow Coverage Ratio
3.16N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
3.95N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
33.09%32.47%32.28%34.74%21.69%27.92%38.11%77.52%19.20%25.74%28.13%21.69%